The global Breast Cancer Screening market is projected to grow from US$ 52 million in 2023 to US$ 85 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.4% during the forecast period.

Breast Cancer Screening Market

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.

A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.

Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent.

In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.

Report Includes:

This report presents an overview of global market for Breast Cancer Screening, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Breast Cancer Screening, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Breast Cancer Screening, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Breast Cancer Screening sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Breast Cancer Screening market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Breast Cancer Screening sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare, Canon Medical, Fujifilm, Metaltronica, Sino Medical-Device and IMS Srl, etc.

Scope of Breast Cancer Screening Market Report

Report Metric	Details
Report Name	Breast Cancer Screening Market
Accounted market size in 2023	US$ 52 million
Forecasted market size in 2029	US$ 85 million
CAGR	8.4
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Mammography Screening Breast Magnetic Resonance Imaging (MRI) Screening Breast Ultrasound Screening
Segment by Application	Hospital Clinic
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare, Canon Medical, Fujifilm, Metaltronica, Sino Medical-Device, IMS Srl
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Breast Cancer Screening in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Breast Cancer Screening manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Breast Cancer Screening sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Breast Cancer Screening Market growing?

Ans: The Breast Cancer Screening Market witnessing a CAGR of 8.4 during the forecast period 2023-2029.

What is the Breast Cancer Screening Market size in 2029?

Ans: The Breast Cancer Screening Market size in 2029 will be US$ 85 million.

What is the market share of major companies in Breast Cancer Screening Market?

Ans: Global top three manufacturers hold a share about 65%.

What is the Breast Cancer Screening Market share by type?

Ans: In terms of product, Mammography Screening is the largest segment, with a share about 70%.

Who are the main players in the Breast Cancer Screening Market report?

Ans: The main players in the Breast Cancer Screening Market are Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare, Canon Medical, Fujifilm, Metaltronica, Sino Medical-Device, IMS Srl

What are the Application segmentation covered in the Breast Cancer Screening Market report?

Ans: The Applications covered in the Breast Cancer Screening Market report are Hospital, Clinic

What are the Type segmentation covered in the Breast Cancer Screening Market report?

Ans: The Types covered in the Breast Cancer Screening Market report are Mammography Screening, Breast Magnetic Resonance Imaging (MRI) Screening, Breast Ultrasound Screening

1 Study Coverage

1.1 Breast Cancer Screening Product Introduction

1.2 Market by Type

1.2.1 Global Breast Cancer Screening Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Mammography Screening

1.2.3 Breast Magnetic Resonance Imaging (MRI) Screening

1.2.4 Breast Ultrasound Screening

1.3 Market by Application

1.3.1 Global Breast Cancer Screening Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Breast Cancer Screening Sales Estimates and Forecasts 2018-2029

2.2 Global Breast Cancer Screening Revenue by Region

2.2.1 Global Breast Cancer Screening Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Breast Cancer Screening Revenue by Region (2018-2023)

2.2.3 Global Breast Cancer Screening Revenue by Region (2024-2029)

2.2.4 Global Breast Cancer Screening Revenue Market Share by Region (2018-2029)

2.3 Global Breast Cancer Screening Sales Estimates and Forecasts 2018-2029

2.4 Global Breast Cancer Screening Sales by Region

2.4.1 Global Breast Cancer Screening Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Breast Cancer Screening Sales by Region (2018-2023)

2.4.3 Global Breast Cancer Screening Sales by Region (2024-2029)

2.4.4 Global Breast Cancer Screening Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Breast Cancer Screening Sales by Manufacturers

3.1.1 Global Breast Cancer Screening Sales by Manufacturers (2018-2023)

3.1.2 Global Breast Cancer Screening Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Breast Cancer Screening in 2022

3.2 Global Breast Cancer Screening Revenue by Manufacturers

3.2.1 Global Breast Cancer Screening Revenue by Manufacturers (2018-2023)

3.2.2 Global Breast Cancer Screening Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Breast Cancer Screening Revenue in 2022

3.3 Global Key Players of Breast Cancer Screening, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Breast Cancer Screening Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Breast Cancer Screening, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Breast Cancer Screening, Product Offered and Application

3.8 Global Key Manufacturers of Breast Cancer Screening, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Breast Cancer Screening Sales by Type

4.1.1 Global Breast Cancer Screening Historical Sales by Type (2018-2023)

4.1.2 Global Breast Cancer Screening Forecasted Sales by Type (2024-2029)

4.1.3 Global Breast Cancer Screening Sales Market Share by Type (2018-2029)

4.2 Global Breast Cancer Screening Revenue by Type

4.2.1 Global Breast Cancer Screening Historical Revenue by Type (2018-2023)

4.2.2 Global Breast Cancer Screening Forecasted Revenue by Type (2024-2029)

4.2.3 Global Breast Cancer Screening Revenue Market Share by Type (2018-2029)

4.3 Global Breast Cancer Screening Price by Type

4.3.1 Global Breast Cancer Screening Price by Type (2018-2023)

4.3.2 Global Breast Cancer Screening Price Forecast by Type (2024-2029)

5 Market Size by Application

5.1 Global Breast Cancer Screening Sales by Application

5.1.1 Global Breast Cancer Screening Historical Sales by Application (2018-2023)

5.1.2 Global Breast Cancer Screening Forecasted Sales by Application (2024-2029)

5.1.3 Global Breast Cancer Screening Sales Market Share by Application (2018-2029)

5.2 Global Breast Cancer Screening Revenue by Application

5.2.1 Global Breast Cancer Screening Historical Revenue by Application (2018-2023)

5.2.2 Global Breast Cancer Screening Forecasted Revenue by Application (2024-2029)

5.2.3 Global Breast Cancer Screening Revenue Market Share by Application (2018-2029)

5.3 Global Breast Cancer Screening Price by Application

5.3.1 Global Breast Cancer Screening Price by Application (2018-2023)

5.3.2 Global Breast Cancer Screening Price Forecast by Application (2024-2029)

6 US & Canada

6.1 US & Canada Breast Cancer Screening Market Size by Type

6.1.1 US & Canada Breast Cancer Screening Sales by Type (2018-2029)

6.1.2 US & Canada Breast Cancer Screening Revenue by Type (2018-2029)

6.2 US & Canada Breast Cancer Screening Market Size by Application

6.2.1 US & Canada Breast Cancer Screening Sales by Application (2018-2029)

6.2.2 US & Canada Breast Cancer Screening Revenue by Application (2018-2029)

6.3 US & Canada Breast Cancer Screening Market Size by Country

6.3.1 US & Canada Breast Cancer Screening Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Breast Cancer Screening Sales by Country (2018-2029)

6.3.3 US & Canada Breast Cancer Screening Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Breast Cancer Screening Market Size by Type

7.1.1 Europe Breast Cancer Screening Sales by Type (2018-2029)

7.1.2 Europe Breast Cancer Screening Revenue by Type (2018-2029)

7.2 Europe Breast Cancer Screening Market Size by Application

7.2.1 Europe Breast Cancer Screening Sales by Application (2018-2029)

7.2.2 Europe Breast Cancer Screening Revenue by Application (2018-2029)

7.3 Europe Breast Cancer Screening Market Size by Country

7.3.1 Europe Breast Cancer Screening Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Breast Cancer Screening Sales by Country (2018-2029)

7.3.3 Europe Breast Cancer Screening Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Breast Cancer Screening Market Size

8.1.1 China Breast Cancer Screening Sales (2018-2029)

8.1.2 China Breast Cancer Screening Revenue (2018-2029)

8.2 China Breast Cancer Screening Market Size by Application

8.2.1 China Breast Cancer Screening Sales by Application (2018-2029)

8.2.2 China Breast Cancer Screening Revenue by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Breast Cancer Screening Market Size by Type

9.1.1 Asia Breast Cancer Screening Sales by Type (2018-2029)

9.1.2 Asia Breast Cancer Screening Revenue by Type (2018-2029)

9.2 Asia Breast Cancer Screening Market Size by Application

9.2.1 Asia Breast Cancer Screening Sales by Application (2018-2029)

9.2.2 Asia Breast Cancer Screening Revenue by Application (2018-2029)

9.3 Asia Breast Cancer Screening Sales by Region

9.3.1 Asia Breast Cancer Screening Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Breast Cancer Screening Revenue by Region (2018-2029)

9.3.3 Asia Breast Cancer Screening Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Breast Cancer Screening Market Size by Type

10.1.1 Middle East, Africa and Latin America Breast Cancer Screening Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Breast Cancer Screening Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Breast Cancer Screening Market Size by Application

10.2.1 Middle East, Africa and Latin America Breast Cancer Screening Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Breast Cancer Screening Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Breast Cancer Screening Sales by Country

10.3.1 Middle East, Africa and Latin America Breast Cancer Screening Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Breast Cancer Screening Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Breast Cancer Screening Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Hologic

11.1.1 Hologic Company Information

11.1.2 Hologic Overview

11.1.3 Hologic Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 Hologic Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Hologic Recent Developments

11.2 GE Healthcare

11.2.1 GE Healthcare Company Information

11.2.2 GE Healthcare Overview

11.2.3 GE Healthcare Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 GE Healthcare Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GE Healthcare Recent Developments

11.3 Siemen Healthineers

11.3.1 Siemen Healthineers Company Information

11.3.2 Siemen Healthineers Overview

11.3.3 Siemen Healthineers Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Siemen Healthineers Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Siemen Healthineers Recent Developments

11.4 Philips Healthcare

11.4.1 Philips Healthcare Company Information

11.4.2 Philips Healthcare Overview

11.4.3 Philips Healthcare Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 Philips Healthcare Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Philips Healthcare Recent Developments

11.5 Canon Medical

11.5.1 Canon Medical Company Information

11.5.2 Canon Medical Overview

11.5.3 Canon Medical Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Canon Medical Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Canon Medical Recent Developments

11.6 Fujifilm

11.6.1 Fujifilm Company Information

11.6.2 Fujifilm Overview

11.6.3 Fujifilm Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2018-2023)

11.6.4 Fujifilm Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Fujifilm Recent Developments

11.7 Metaltronica

11.7.1 Metaltronica Company Information

11.7.2 Metaltronica Overview

11.7.3 Metaltronica Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2018-2023)

11.7.4 Metaltronica Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Metaltronica Recent Developments

11.8 Sino Medical-Device

11.8.1 Sino Medical-Device Company Information

11.8.2 Sino Medical-Device Overview

11.8.3 Sino Medical-Device Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2018-2023)

11.8.4 Sino Medical-Device Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Sino Medical-Device Recent Developments

11.9 IMS Srl

11.9.1 IMS Srl Company Information

11.9.2 IMS Srl Overview

11.9.3 IMS Srl Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2018-2023)

11.9.4 IMS Srl Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 IMS Srl Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Breast Cancer Screening Industry Chain Analysis

12.2 Breast Cancer Screening Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Breast Cancer Screening Production Mode & Process

12.4 Breast Cancer Screening Sales and Marketing

12.4.1 Breast Cancer Screening Sales Channels

12.4.2 Breast Cancer Screening Distributors

12.5 Breast Cancer Screening Customers

13 Market Dynamics

13.1 Breast Cancer Screening Industry Trends

13.2 Breast Cancer Screening Market Drivers

13.3 Breast Cancer Screening Market Challenges

13.4 Breast Cancer Screening Market Restraints

14 Key Findings in The Global Breast Cancer Screening Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Breast Cancer Screening Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Table 2. Major Manufacturers of Mammography Screening

Table 3. Major Manufacturers of Breast Magnetic Resonance Imaging (MRI) Screening

Table 4. Major Manufacturers of Breast Ultrasound Screening

Table 5. Global Breast Cancer Screening Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Table 6. Global Breast Cancer Screening Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. Global Breast Cancer Screening Revenue by Region (2018-2023) & (US$ Million)

Table 8. Global Breast Cancer Screening Revenue by Region (2024-2029) & (US$ Million)

Table 9. Global Breast Cancer Screening Revenue Market Share by Region (2018-2023)

Table 10. Global Breast Cancer Screening Revenue Market Share by Region (2024-2029)

Table 11. Global Breast Cancer Screening Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 12. Global Breast Cancer Screening Sales by Region (2018-2023) & (Units)

Table 13. Global Breast Cancer Screening Sales by Region (2024-2029) & (Units)

Table 14. Global Breast Cancer Screening Sales Market Share by Region (2018-2023)

Table 15. Global Breast Cancer Screening Sales Market Share by Region (2024-2029)

Table 16. Global Breast Cancer Screening Sales by Manufacturers (2018-2023) & (Units)

Table 17. Global Breast Cancer Screening Sales Share by Manufacturers (2018-2023)

Table 18. Global Breast Cancer Screening Revenue by Manufacturers (2018-2023) & (US$ Million)

Table 19. Global Breast Cancer Screening Revenue Share by Manufacturers (2018-2023)

Table 20. Global Key Players of Breast Cancer Screening, Industry Ranking, 2021 VS 2022 VS 2023

Table 21. Breast Cancer Screening Price by Manufacturers 2018-2023 (K USD/Unit)

Table 22. Global Breast Cancer Screening Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Breast Cancer Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Screening as of 2022)

Table 24. Global Key Manufacturers of Breast Cancer Screening, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Breast Cancer Screening, Product Offered and Application

Table 26. Global Key Manufacturers of Breast Cancer Screening, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Breast Cancer Screening Sales by Type (2018-2023) & (Units)

Table 29. Global Breast Cancer Screening Sales by Type (2024-2029) & (Units)

Table 30. Global Breast Cancer Screening Sales Share by Type (2018-2023)

Table 31. Global Breast Cancer Screening Sales Share by Type (2024-2029)

Table 32. Global Breast Cancer Screening Revenue by Type (2018-2023) & (US$ Million)

Table 33. Global Breast Cancer Screening Revenue by Type (2024-2029) & (US$ Million)

Table 34. Global Breast Cancer Screening Revenue Share by Type (2018-2023)

Table 35. Global Breast Cancer Screening Revenue Share by Type (2024-2029)

Table 36. Breast Cancer Screening Price by Type (2018-2023) & (K USD/Unit)

Table 37. Global Breast Cancer Screening Price Forecast by Type (2024-2029) & (K USD/Unit)

Table 38. Global Breast Cancer Screening Sales by Application (2018-2023) & (Units)

Table 39. Global Breast Cancer Screening Sales by Application (2024-2029) & (Units)

Table 40. Global Breast Cancer Screening Sales Share by Application (2018-2023)

Table 41. Global Breast Cancer Screening Sales Share by Application (2024-2029)

Table 42. Global Breast Cancer Screening Revenue by Application (2018-2023) & (US$ Million)

Table 43. Global Breast Cancer Screening Revenue by Application (2024-2029) & (US$ Million)

Table 44. Global Breast Cancer Screening Revenue Share by Application (2018-2023)

Table 45. Global Breast Cancer Screening Revenue Share by Application (2024-2029)

Table 46. Breast Cancer Screening Price by Application (2018-2023) & (K USD/Unit)

Table 47. Global Breast Cancer Screening Price Forecast by Application (2024-2029) & (K USD/Unit)

Table 48. US & Canada Breast Cancer Screening Sales by Type (2018-2023) & (Units)

Table 49. US & Canada Breast Cancer Screening Sales by Type (2024-2029) & (Units)

Table 50. US & Canada Breast Cancer Screening Revenue by Type (2018-2023) & (US$ Million)

Table 51. US & Canada Breast Cancer Screening Revenue by Type (2024-2029) & (US$ Million)

Table 52. US & Canada Breast Cancer Screening Sales by Application (2018-2023) & (Units)

Table 53. US & Canada Breast Cancer Screening Sales by Application (2024-2029) & (Units)

Table 54. US & Canada Breast Cancer Screening Revenue by Application (2018-2023) & (US$ Million)

Table 55. US & Canada Breast Cancer Screening Revenue by Application (2024-2029) & (US$ Million)

Table 56. US & Canada Breast Cancer Screening Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 57. US & Canada Breast Cancer Screening Revenue by Country (2018-2023) & (US$ Million)

Table 58. US & Canada Breast Cancer Screening Revenue by Country (2024-2029) & (US$ Million)

Table 59. US & Canada Breast Cancer Screening Sales by Country (2018-2023) & (Units)

Table 60. US & Canada Breast Cancer Screening Sales by Country (2024-2029) & (Units)

Table 61. Europe Breast Cancer Screening Sales by Type (2018-2023) & (Units)

Table 62. Europe Breast Cancer Screening Sales by Type (2024-2029) & (Units)

Table 63. Europe Breast Cancer Screening Revenue by Type (2018-2023) & (US$ Million)

Table 64. Europe Breast Cancer Screening Revenue by Type (2024-2029) & (US$ Million)

Table 65. Europe Breast Cancer Screening Sales by Application (2018-2023) & (Units)

Table 66. Europe Breast Cancer Screening Sales by Application (2024-2029) & (Units)

Table 67. Europe Breast Cancer Screening Revenue by Application (2018-2023) & (US$ Million)

Table 68. Europe Breast Cancer Screening Revenue by Application (2024-2029) & (US$ Million)

Table 69. Europe Breast Cancer Screening Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 70. Europe Breast Cancer Screening Revenue by Country (2018-2023) & (US$ Million)

Table 71. Europe Breast Cancer Screening Revenue by Country (2024-2029) & (US$ Million)

Table 72. Europe Breast Cancer Screening Sales by Country (2018-2023) & (Units)

Table 73. Europe Breast Cancer Screening Sales by Country (2024-2029) & (Units)

Table 74. China Breast Cancer Screening Sales by Type (2018-2023) & (Units)

Table 75. China Breast Cancer Screening Sales by Type (2024-2029) & (Units)

Table 76. China Breast Cancer Screening Revenue by Type (2018-2023) & (US$ Million)

Table 77. China Breast Cancer Screening Revenue by Type (2024-2029) & (US$ Million)

Table 78. China Breast Cancer Screening Sales by Application (2018-2023) & (Units)

Table 79. China Breast Cancer Screening Sales by Application (2024-2029) & (Units)

Table 80. China Breast Cancer Screening Revenue by Application (2018-2023) & (US$ Million)

Table 81. China Breast Cancer Screening Revenue by Application (2024-2029) & (US$ Million)

Table 82. Asia Breast Cancer Screening Sales by Type (2018-2023) & (Units)

Table 83. Asia Breast Cancer Screening Sales by Type (2024-2029) & (Units)

Table 84. Asia Breast Cancer Screening Revenue by Type (2018-2023) & (US$ Million)

Table 85. Asia Breast Cancer Screening Revenue by Type (2024-2029) & (US$ Million)

Table 86. Asia Breast Cancer Screening Sales by Application (2018-2023) & (Units)

Table 87. Asia Breast Cancer Screening Sales by Application (2024-2029) & (Units)

Table 88. Asia Breast Cancer Screening Revenue by Application (2018-2023) & (US$ Million)

Table 89. Asia Breast Cancer Screening Revenue by Application (2024-2029) & (US$ Million)

Table 90. Asia Breast Cancer Screening Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 91. Asia Breast Cancer Screening Revenue by Region (2018-2023) & (US$ Million)

Table 92. Asia Breast Cancer Screening Revenue by Region (2024-2029) & (US$ Million)

Table 93. Asia Breast Cancer Screening Sales by Region (2018-2023) & (Units)

Table 94. Asia Breast Cancer Screening Sales by Region (2024-2029) & (Units)

Table 95. Middle East, Africa and Latin America Breast Cancer Screening Sales by Type (2018-2023) & (Units)

Table 96. Middle East, Africa and Latin America Breast Cancer Screening Sales by Type (2024-2029) & (Units)

Table 97. Middle East, Africa and Latin America Breast Cancer Screening Revenue by Type (2018-2023) & (US$ Million)

Table 98. Middle East, Africa and Latin America Breast Cancer Screening Revenue by Type (2024-2029) & (US$ Million)

Table 99. Middle East, Africa and Latin America Breast Cancer Screening Sales by Application (2018-2023) & (Units)

Table 100. Middle East, Africa and Latin America Breast Cancer Screening Sales by Application (2024-2029) & (Units)

Table 101. Middle East, Africa and Latin America Breast Cancer Screening Revenue by Application (2018-2023) & (US$ Million)

Table 102. Middle East, Africa and Latin America Breast Cancer Screening Revenue by Application (2024-2029) & (US$ Million)

Table 103. Middle East, Africa and Latin America Breast Cancer Screening Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 104. Middle East, Africa and Latin America Breast Cancer Screening Revenue by Country (2018-2023) & (US$ Million)

Table 105. Middle East, Africa and Latin America Breast Cancer Screening Revenue by Country (2024-2029) & (US$ Million)

Table 106. Middle East, Africa and Latin America Breast Cancer Screening Sales by Country (2018-2023) & (Units)

Table 107. Middle East, Africa and Latin America Breast Cancer Screening Sales by Country (2024-2029) & (Units)

Table 108. Hologic Company Information

Table 109. Hologic Description and Major Businesses

Table 110. Hologic Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 111. Hologic Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Hologic Recent Developments

Table 113. GE Healthcare Company Information

Table 114. GE Healthcare Description and Major Businesses

Table 115. GE Healthcare Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 116. GE Healthcare Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. GE Healthcare Recent Developments

Table 118. Siemen Healthineers Company Information

Table 119. Siemen Healthineers Description and Major Businesses

Table 120. Siemen Healthineers Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 121. Siemen Healthineers Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Siemen Healthineers Recent Developments

Table 123. Philips Healthcare Company Information

Table 124. Philips Healthcare Description and Major Businesses

Table 125. Philips Healthcare Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 126. Philips Healthcare Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Philips Healthcare Recent Developments

Table 128. Canon Medical Company Information

Table 129. Canon Medical Description and Major Businesses

Table 130. Canon Medical Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 131. Canon Medical Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Canon Medical Recent Developments

Table 133. Fujifilm Company Information

Table 134. Fujifilm Description and Major Businesses

Table 135. Fujifilm Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 136. Fujifilm Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Fujifilm Recent Developments

Table 138. Metaltronica Company Information

Table 139. Metaltronica Description and Major Businesses

Table 140. Metaltronica Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 141. Metaltronica Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Metaltronica Recent Developments

Table 143. Sino Medical-Device Company Information

Table 144. Sino Medical-Device Description and Major Businesses

Table 145. Sino Medical-Device Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 146. Sino Medical-Device Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Sino Medical-Device Recent Developments

Table 148. IMS Srl Company Information

Table 149. IMS Srl Description and Major Businesses

Table 150. IMS Srl Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2018-2023)

Table 151. IMS Srl Breast Cancer Screening Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. IMS Srl Recent Developments

Table 153. Key Raw Materials Lists

Table 154. Raw Materials Key Suppliers Lists

Table 155. Breast Cancer Screening Distributors List

Table 156. Breast Cancer Screening Customers List

Table 157. Breast Cancer Screening Market Trends

Table 158. Breast Cancer Screening Market Drivers

Table 159. Breast Cancer Screening Market Challenges

Table 160. Breast Cancer Screening Market Restraints

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

List of Figures

Figure 1. Breast Cancer Screening Product Picture

Figure 2. Global Breast Cancer Screening Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Breast Cancer Screening Market Share by Type in 2022 & 2029

Figure 4. Mammography Screening Product Picture

Figure 5. Breast Magnetic Resonance Imaging (MRI) Screening Product Picture

Figure 6. Breast Ultrasound Screening Product Picture

Figure 7. Global Breast Cancer Screening Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 8. Global Breast Cancer Screening Market Share by Application in 2022 & 2029

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Breast Cancer Screening Report Years Considered

Figure 12. Global Breast Cancer Screening Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Breast Cancer Screening Revenue 2018-2029 (US$ Million)

Figure 14. Global Breast Cancer Screening Revenue Market Share by Region in Percentage: 2022 Versus 2029

Figure 15. Global Breast Cancer Screening Revenue Market Share by Region (2018-2029)

Figure 16. Global Breast Cancer Screening Sales 2018-2029 ((Units)

Figure 17. Global Breast Cancer Screening Sales Market Share by Region (2018-2029)

Figure 18. US & Canada Breast Cancer Screening Sales YoY (2018-2029) & (Units)

Figure 19. US & Canada Breast Cancer Screening Revenue YoY (2018-2029) & (US$ Million)

Figure 20. Europe Breast Cancer Screening Sales YoY (2018-2029) & (Units)

Figure 21. Europe Breast Cancer Screening Revenue YoY (2018-2029) & (US$ Million)

Figure 22. China Breast Cancer Screening Sales YoY (2018-2029) & (Units)

Figure 23. China Breast Cancer Screening Revenue YoY (2018-2029) & (US$ Million)

Figure 24. Asia (excluding China) Breast Cancer Screening Sales YoY (2018-2029) & (Units)

Figure 25. Asia (excluding China) Breast Cancer Screening Revenue YoY (2018-2029) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Breast Cancer Screening Sales YoY (2018-2029) & (Units)

Figure 27. Middle East, Africa and Latin America Breast Cancer Screening Revenue YoY (2018-2029) & (US$ Million)

Figure 28. The Breast Cancer Screening Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

Figure 29. The Top 5 and 10 Largest Manufacturers of Breast Cancer Screening in the World: Market Share by Breast Cancer Screening Revenue in 2022

Figure 30. Global Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 31. Global Breast Cancer Screening Sales Market Share by Type (2018-2029)

Figure 32. Global Breast Cancer Screening Revenue Market Share by Type (2018-2029)

Figure 33. Global Breast Cancer Screening Sales Market Share by Application (2018-2029)

Figure 34. Global Breast Cancer Screening Revenue Market Share by Application (2018-2029)

Figure 35. US & Canada Breast Cancer Screening Sales Market Share by Type (2018-2029)

Figure 36. US & Canada Breast Cancer Screening Revenue Market Share by Type (2018-2029)

Figure 37. US & Canada Breast Cancer Screening Sales Market Share by Application (2018-2029)

Figure 38. US & Canada Breast Cancer Screening Revenue Market Share by Application (2018-2029)

Figure 39. US & Canada Breast Cancer Screening Revenue Share by Country (2018-2029)

Figure 40. US & Canada Breast Cancer Screening Sales Share by Country (2018-2029)

Figure 41. U.S. Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 42. Canada Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 43. Europe Breast Cancer Screening Sales Market Share by Type (2018-2029)

Figure 44. Europe Breast Cancer Screening Revenue Market Share by Type (2018-2029)

Figure 45. Europe Breast Cancer Screening Sales Market Share by Application (2018-2029)

Figure 46. Europe Breast Cancer Screening Revenue Market Share by Application (2018-2029)

Figure 47. Europe Breast Cancer Screening Revenue Share by Country (2018-2029)

Figure 48. Europe Breast Cancer Screening Sales Share by Country (2018-2029)

Figure 49. Germany Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 50. France Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 51. U.K. Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 52. Italy Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 53. Russia Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 54. China Breast Cancer Screening Sales Market Share by Type (2018-2029)

Figure 55. China Breast Cancer Screening Revenue Market Share by Type (2018-2029)

Figure 56. China Breast Cancer Screening Sales Market Share by Application (2018-2029)

Figure 57. China Breast Cancer Screening Revenue Market Share by Application (2018-2029)

Figure 58. Asia Breast Cancer Screening Sales Market Share by Type (2018-2029)

Figure 59. Asia Breast Cancer Screening Revenue Market Share by Type (2018-2029)

Figure 60. Asia Breast Cancer Screening Sales Market Share by Application (2018-2029)

Figure 61. Asia Breast Cancer Screening Revenue Market Share by Application (2018-2029)

Figure 62. Asia Breast Cancer Screening Revenue Share by Region (2018-2029)

Figure 63. Asia Breast Cancer Screening Sales Share by Region (2018-2029)

Figure 64. Japan Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 65. South Korea Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 66. China Taiwan Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 67. Southeast Asia Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 68. India Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 69. Middle East, Africa and Latin America Breast Cancer Screening Sales Market Share by Type (2018-2029)

Figure 70. Middle East, Africa and Latin America Breast Cancer Screening Revenue Market Share by Type (2018-2029)

Figure 71. Middle East, Africa and Latin America Breast Cancer Screening Sales Market Share by Application (2018-2029)

Figure 72. Middle East, Africa and Latin America Breast Cancer Screening Revenue Market Share by Application (2018-2029)

Figure 73. Middle East, Africa and Latin America Breast Cancer Screening Revenue Share by Country (2018-2029)

Figure 74. Middle East, Africa and Latin America Breast Cancer Screening Sales Share by Country (2018-2029)

Figure 75. Brazil Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 76. Mexico Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 77. Turkey Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 78. Israel Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 79. GCC Countries Breast Cancer Screening Revenue (2018-2029) & (US$ Million)

Figure 80. Breast Cancer Screening Value Chain

Figure 81. Breast Cancer Screening Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions